Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q1 Net Income USD -29.281 Million

Apr 30 (Reuters) - Larimar Therapeutics Q1 basic EPS USD -0.46.

Q1 operating expenses USD 31.188 million

Q1 income from operations USD -31.188 million

Recent news on Larimar Therapeutics

See all news